Bufalin inhibits proliferation and downregulates expression of WT1 in K562 cells in vivo and vitro
10.3969/j.issn.1001-1978.2016.02.016
- VernacularTitle:蟾蜍灵在体内外抑制急性红白血病细胞K562增殖及下调WT1表达的研究
- Author:
Lipei WANG
;
Tianyi LI
;
Ruilan GAO
;
Yueguang DU
;
Yanna ZHAO
- Publication Type:Journal Article
- Keywords:
bufalin;
WT1;
K562;
cell cycle;
G0/G1 phase;
subcutaneous tumor
- From:
Chinese Pharmacological Bulletin
2016;(2):229-233
- CountryChina
- Language:Chinese
-
Abstract:
Aim To investigate the effect of bufalin on proliferation and expression of WT1 in K562 cells. Methods The colony number of K562 cell was detec-ted with semi-solid culture assay. The cell cycle was measured by flowcytometry, and the expression of WT1 was observed with immunocytochemistry. Subcutaneous tumor models established by K562 cells in BALB/C nu/nu mice were divided into three groups, including model group, bufalin group and positive control group. After 21 days, the subcutaneous tumors were removed for calculating the inhibitory rate of tumor growth. HE staining and immunohistochemistry were used to ob-serve the morphological changes and the expression of WT1 . Results ① Bufalin could significantly decrease the colony number of K562 cell, arrest it at G0/G1 phase and down-regulate its expression of WT1 in a dose-dependent manner. ② Compared with the model group, the tumor inhibitory rate was much higher, while the volume and the weight were obviously lower in the other two groups. ③Bufalin could induce apop-tosis, necrosis, hemorrhage and fibrosis with HE stai-ning, and down-regulate the expression of WT1. Con-clusion Bufalin could inhibit the proliferation, arrest the cell cycle at G0/G1 phase and down-regulate the expression of WT1 in vitro. Bufalin could inhibit the tumor inhibitory rate, the volume and the weight of the subcutaneous tumors, induce apoptosis, necrosis, hemorrhage and fibrosis with HE staining and down-regulate the expression of WT1 .
